Clinician Summary
Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication
August 01, 2023
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
What does the USPSTF recommend? |
Persons who plan to or could become pregnant: |
To whom does this recommendation apply? | This recommendation applies to all persons who are planning to or could become pregnant. It does not apply to persons who have had a previous pregnancy affected by neural tube defects or who are at very high risk due to other factors such as family history or those taking medication known to block the function of folic acid. |
What’s new? | This recommendation is consistent with the 2017 USPSTF recommendation. |
How to implement this recommendation? | All persons who are planning to or could become pregnant should take a daily supplement or multivitamin containing 0.4 to 0.8 mg (400 to 800 μg) of folic acid. |
What additional information should clinicians know about this recommendation? |
|
Why is this recommendation and topic important? |
|
What are additional tools and resources? | The Community Preventive Services Task Force recommends community-wide education campaigns to promote the use of folic acid supplements among persons of childbearing age (https://www.thecommunityguide.org/findings/pregnancy-health-community-wide-campaigns-promote-use-folic-acid-supplements.html). |
Where to read the full recommendation statement? | Visit the USPSTF website (https://www.uspreventiveservicestaskforce.org/) or the JAMA website (https://jamanetwork.com/collections/44068/united-states-preventive-services-task-force) to read the full recommendation statement. This includes more details on the rationale of the recommendation, including benefits and harms; supporting evidence; and recommendations of others. |
The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision making to the specific patient or situation.